This is one of the few studies analyzing the usefulness of EBC in monitoring treatment response to antifibrotic agents in patients with IPF and, to our knowledge, the first study to assess IL-6, IL-8, IL-15, TNF-α and VEGF-A in EBC from patients with IPF. The gene discussed is CXCL8; the disease is idiopathic pulmonary fibrosis.